Clinton Announces Deal For Low-Cost Second-Line Antiretroviral Drugs, HIV Tests

... Former President Clinton on Thursday announced an agreement reached by the Clinton Foundation that will allow the sale of antiretroviral drugs efavirenz and abacavir, as well as HIV tests, at a lower cost in developing countries (Wilson, "All Things Considered," NPR, 1/12). This is the first time the foundation has reduced prices for second-line AIDS drugs, antiretrovirals taken by patients who have developed resistance to first-line treatments... click link for more info. ...